ProQR Announces Planned Changes to Board Composition
Stocks in this Quantisnow insightHealth Care
Historical context for PRQR
Across the 3 sessions after earlier PRQR headlines, the stock closed higher 1 times and lower 2 times, with a median move of 9.4% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | PRQR | SPY |
|---|---|---|---|
| Jan 8, 2026 | ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook | -2.8% | -0.0% |
| Dec 1, 2025 | ProQR to Participate in 8th Annual Evercore Healthcare Conference | -9.4% | -0.5% |
| Oct 20, 2025 | ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025 | +9.7% | +1.0% |
Quantisnow market dataNASDAQ
PRQR
ProQR Therapeutics N.V.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2014
Get push alerts for PRQR
Full PRQR profile on Quantisnow Follow PRQR and get a push notification the moment its next story breaks.